Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update

Go back to Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update

Prothena Corp. (PRTA) Posts Smaller Q4 Loss

February 14, 2019 4:08 PM EST

Prothena Corp. (NASDAQ: PRTA) reported Q4 EPS of ($0.56), $0.38 better than the analyst estimate of ($0.94). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $200 thousand.

Net cash used in operating and investing activities was $22.5 million in the fourth quarter and $30.0... More